This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. This issue profiles research by Sandia for boosting thermoelectric nanowire efficiency, gold nanoprobes for cancer diagnostics, and Sandia research on converting biological cells to stone

    $250.00
  2. This issue profiles a fully integrated, high capacity, next generation sequencing system; an ebola diagnostic kit by China that has been approved by the WHO; and CRISPR associated protein 9 mediated gene editing in human embryo.

    $250.00
  3. This issue profiles research that has identified a variant of gene type linking cholesterol with cardiovascular disease; a genetic variant that identifies the likelihood of patient's response to treatment for multiple sclerosis, and cancer treatment by telomere inhibition.

    $250.00
  4. This issue profiles recent advances and opportunities for innovation in drug-eluting stents.

    $750.00
  5. This issue profiles an universal immune stimulatory peptide, site specific immunomodulators to cure inflammatory bowel disease and cancer, and a drug that is used to treat tumors can also target cancer stem cells.

    $250.00
  6. This issue profiles a molecular pathway that holds the key to suppress children's cancer, destroying chemical weapons safely, and R&D on datacenter cabling at HP Laboratories.

    $250.00
  7. This issue profiles an affordable and customisable radiotherapy system, a remote telerobotic ultrasound imaging platform, and affordable digital radiography systems for low-income countries.

    $950.00
  8. This issue profiles cancerous growth inhibited by a kinase inhibitor, patient-driven oncological therapeutic solutions using cancer genomic foundation, and multiple kinase inhibitors targeting oncological disorders that are currently in clinical trials.

    $250.00
  9. This issue profiles using an annuloplasty ring to treat mitral regurgitation, a novel leadless artificial cardiac pacemaker, and 3D printed medical devices that are on the rise.

    $950.00
  10. This issue profiles a genome editing technology for treatment of blood cancer, a genetic risk assessment test for non-hereditary breast cancer, and rapid detection of infectious disease through innovations in molecular diagnostics.

    $250.00